https://en.bioecon.ru/companies/medtronic/Recent content in Medtronic on BioeconHugoen-USMon, 20 Jul 2026 16:57:13 +0700https://en.bioecon.ru/technology/implantable-biosensors-chronic-disease/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/implantable-biosensors-chronic-disease/Surgically or subcutaneously implanted sensors that continuously monitor a chronic-disease parameter for months to years without an external wearable — implantable continuous glucose monitors and insertable cardiac monitors — distinct from external wearables and ingested/swallowed sensors: Senseonics’ Eversense 365 in the US, Medtronic’s LINQ II and Boston Scientific’s LUX-Dx cardiac monitors in the US, Biotronik’s BIOMONITOR in Germany, and MicroPort in China.https://en.bioecon.ru/technology/ingestible-biosensors-smart-pills/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/ingestible-biosensors-smart-pills/Swallowed capsule devices that image the GI tract or confirm medication ingestion as they transit the body, requiring no sedation or implantation — distinct from surgically implanted sensors: Medtronic’s PillCam and CapsoVision’s CapsoCam capsule endoscopy in the US, etectRx’s ID-Cap ingestible event marker in the US, and Ankon Technologies’ magnetically controlled capsule endoscopy in China.https://en.bioecon.ru/technology/biomedical-engineering-implants/Sun, 28 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/biomedical-engineering-implants/The engineering of medical devices that interface with the body — orthopedic, cardiovascular and neuro implants — sold as capital robotic systems, per-procedure implants and regulated biomaterials under FDA, EU MDR and NMPA oversight.